What Explains Emerging Markets’ Relatively Low COVID-19 Fatality Rate? (LGIM)

Our new research suggests that emerging markets may be less vulnerable to the current crisis than previously thought.

Emerging markets have reported far fewer fatalities from COVID-19 than advanced economies at similar stages of the pandemic. Specifically, 30 days into an outbreak of the virus – measured from the day a country’s death toll surpassed 20 – emerging markets report almost 90% fewer fatalities than their developed market peers. READ MORE

Similar Posts:

• Deciphering the Frontier Market Opportunity (Lazard)
• South Korea Facing Worst Labor Market Crisis Since 1997 (Nikkei Asia)
• Which Emerging Markets May Benefit Most from the Rebound in China and the DM? (PGIM Fixed Income)
• North Asia vs South Asia: Differentiation is Key (DWS)
• The Emerging Emerging-Markets Crisis (Guggenheim Investments)
• Three Reasons We Remain Bullish on Emerging Markets Long Term (Franklin Templeton)
• No Emerging Markets Crisis According to Mark Mobius (FE Trustnet)
• Is Now the Right Time to Invest in Frontier Markets? (Portfolio Adviser)
• Frontier Markets: Attractive Valuations with Limited Correlation (Mobius Blog)
• Lazard Emerging Markets Fund Manager: Full-blown Financial Crisis in China is Unlikely (FE Trustnet)
• Tech and the Consumer have Reshaped Today’s Emerging Markets (Manulife IM)
• Asia and Emerging Markets Had the Worst Dividend Growth Rates for 1Q2014 (FE Trustnet)
• Is South Korea Crowding Your Emerging Markets Allocation? (S&P Dow Jones)
• Miners From Emerging Markets Outperform Peers From Developed Countries (PwC)
• JP Morgan’s Gartside: Currencies Now Bear the Blunt of Political Risk